This Is Why Ocular Therapeutix Inc.’s Stock Hit the Ceiling Today – July 11, 2017
A few days ago, shares of biopharmaceutical startup Ocular Therapeutix (NASDAQ:$OCUL) were plummeting — but on July 11, the company’s shares shot up by 26%. This is largely due to the fact that Ocular Therapeutix ... [Read]
This is Why Shares of Ocular Therapeutix Inc. Spiraled Today – July 7, 2017
As of around 4:50 PM EDT on July 7, 2017, Ocular Therapeutix Inc.’s (NASDAQ:$OCUL) stocks have fallen by 25.05% to $7.12 from its $9.05 opening this morning. The dramatic fall occurred after Adam Feuerstein at ... [Read]
Adamis Pharmaceuticals’ Shares Hits New Highs After Allergic-Reaction Treatment Drug Gains FDA Approval
Investors in Adamis Pharmaceuticals Corp. (NASDAQ:$ADMP) were probably celebrating yesterday as the company’s shares flew through the roof by a whopping 53%, hitting a one-year high. The rise was largely due to Adamis’ announcement that ... [Read]
Epizyme Stock Rises with Positive Media Coverage, According to Analysis
Media coverage of biopharmaceutical company Epizyme (NASDAQ:$EPZM) has been pretty positive recently, according to research group Alpha One Sentiment Analysis. Alpha One helps company identify positive and/or negative media coverage through the analysis of more ... [Read]
Oasmia Pharmaceutical’s Stock Increases After Company Signs Deal with Hetero Group
If you’re looking for the best pharmaceutical companies to invest in, you should know that Oasmia Pharmaceutical AB (STO:$OASM), a Swedish company that focuses on the development of drugs within the fields of human and ... [Read]
RedHill Biopharma Ltd – ADR Stock Rises After Positive Phase III Results of BEKINDA Treatment
Israel-based biopharmaceutical company RedHill Biopharma Ltd – ADR (NASDAQ:$RDHL) saw its stocks rise after the company’s release of the results from its Phase III clinical trial named GUARD. GUARD tested the performance of using RHB-102 ... [Read]
Depomed, Inc. Trades Just Under the 50 Day Moving Average
Depomed Inc. (NASDAQ:$DEPO), an American pharmaceutical company, is down from yesterday’s close of $9.84. Currently, the California-based company is trading at $9.58 which is slightly under the $10.89 50-day moving average, and just below the ... [Read]
Omeros Corporation’s Stock Sees a High Rise of Almost 17%
Shareholders of Seattle-based biopharmaceutical company Omeros Corporation (NASDAQ:$OMER) are definitely celebrating today thanks to the almost-17% rise in Omeros’ share price. The sudden spike is largely in response to the company’s announcement that the U.S. ... [Read]